Epigenetics in Cancer Scientific Symposium
Cancer genomics has revealed that epigenetic pathways are frequently mutated in different tumor types. Epigenetic therapy is now emerging as one of the most promising tools to treat cancer. In this symposium, we brought together leaders in epigenetics research to discuss the most recent advances in the field and their potential translational applications.
This symposium was sponsored by The Wistar Institute's Gene Expression and Regulation Program.
WHAT: Epigenetics in Cancer Scientific Symposium
WHEN: April 25, 2017, 9:30 a.m. - 5 p.m. (lunch provided)
WHERE: The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104
Thank you to our industry sponsors for helping make this event possible.